Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Embla Medical – A look back at 2024 with CEO

By Michael FriisHead of Equities
Embla Medical

With a share price return of +30%, Embla Medical has outperformed both the Danish stock market and the European Medtech sector. Together with Embla Medical’s CEO Sveinn Solvason, we looked back at the main achievements in 2024 and the key drivers behind the results.

In the interview, you can hear more about the main headlines for Embla Medical, how 2024 has positioned the company to deliver on the 2027 strategy, and lastly which milestones investors should look out for in 2025.

Disclaimer: HC Andersen Capital receives payment from Embla Medical for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis, 09:26, 06-12-2024.

Recent videos

AKTIER MED FRIIS - UGE 50 2025
12.12.2025, 12.00
HCA Morgenbørs 12/12 - Positive futures og fokus på FLSmidth og fedme aktier
12.12.2025, 09.27 Novo Nordisk
A sit-down with CEO Remco Westermann
12.12.2025, 09.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025, 11.00 Aiforia Technologies
HCA Morgenbørs 11/12 - Flade europæiske futures, Oracle skaber usikkerhed om AI
11.12.2025, 09.45 GreenMobility
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.